Download PDF
Thromb Haemost 1968; 20(03/04): 397-408
DOI: 10.1055/s-0038-1651282
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Effect of Venous Occlusion on Coagulation and Fibrinolytic Components in Normal Subjects[*]

Inga Marie Nilsson
1   Coagulation Laboratory and the Department of Surgery, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
B Robertson
1   Coagulation Laboratory and the Department of Surgery, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The components of the coagulation and fibrinolytic systems were studied before and during venous occlusion for 20 min of the arm and of the leg in 30 healthy volunteers. For comparison total serum proteins, α2-macroglobulin and albumin were also determined. The values recorded after venous occlusion were corrected according to the changes in the haematocrit.

The fibrinolytic activity induced by venous occlusion was markedly higher (4 to 6 times) in the arms than in the legs. In 2 of the subjects, however, venous occlusion was not followed by any increase of fibrinolysis.

After venous occlusion total serum proteins increased by 15% but albumin only by 2%. The P & P, AHF, haemophilia B-factor and fibrinogen increased by 5-20%. The factor V-level remained unchanged. The AHF and factors XI and XII increased by about 20% in the legs but by about 40% in the arms. In other respects the upper and lower limbs showed the same type of coagulation changes.

The plasminogen level increased in both arms and legs by 10%. The inhibitors of urokinase activation and the α2M remained unchanged, which means that these inhibitors compared with the increase in total serum proteins had decreased by about 10%.

The 2 normals, in whom venous occlusion failed to produce any increase of fibrinolysis, had no signs of Hageman trait and after venous stasis the same coagulation changes occurred as in the individuals who developed high fibrinolytic activity.

The findings argue against the Hageman factor playing an essential role in the activation of the fibrinolytic system during venous occlusion and indicate that the increase in fibrinolysis is due to release of activators from the vessel walls.

* The investigation was supported by grants from the Swedish Medical Research Council (B68-19X-87-04A, B68-40X-678-03) and from the Faculty of Medicine, the University of Lund.


 

  • References

  • 1 Amery A, Vermylen J, Maes H, Verstraete M. Enhancing the fibrinolytic activity in human blood by occlusion of blood vessels 1. The appearance of the phenomenon. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 70
    PubMedGoogle Scholar
  • 2 Clarke R.L, Orandi A, Cliffton E.E. Induction of fibrinolysis by venous obstruction. Angiology 1960; 11: 367
    CrossrefPubMedGoogle Scholar
  • 3 Cliffton E.E, Clarke R.L, Murphy J. Studies on fibrinolytic activity with venous occlusion : treatment of thrombophlebitis. Surgery 1961; 50: 64
    PubMedGoogle Scholar
  • 4 Cronberg S, Nilsson I.M, Silwer J. Studies on the platelet adhesiveness in von Willebrand's disease. Acta med. scand 1966; 180: 43
    PubMedGoogle Scholar
  • 5 Egeberg O. The effect of venous congestion on the blood clotting system. Scand. J. clin. Lab. Invest 1963; 15: 20
    CrossrefPubMedGoogle Scholar
  • 6 Fearnley GR. Fibrinolysis Edward Arnold (publishers) LTD. 1965
    PubMed
  • 7 Ganrot P.O. Determination of α2-macroglobulin as trypsinprotein esterase. Clin. chim. Acta 1966; 14: 493
    CrossrefPubMedGoogle Scholar
  • 8 Ganrot P.O, Niléhn J.-E. Competition between plasmin and thrombin for α2-macroglobulin. Clin. chim. Acta 1967; 17: 511
    CrossrefPubMedGoogle Scholar
  • 9 Geyer G, Keibl E, Kölbl H. Über Beziehungen zwischen Permeabilität und Eiweißdurchlässigkeit der Kapillaren. Z. ges. exp. Med 1953; 122: 1
    CrossrefPubMedGoogle Scholar
  • 10 Hedner U, Nilsson I.M. Determination of plasminogen in human plasma by casein method. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 545
    PubMedGoogle Scholar
  • 11 Hellem A.J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. Suppl 1960; 12: 1
    CrossrefPubMedGoogle Scholar
  • 12 Holemans R. Increase in fibrinolytic activity by venous occlusion. J. appl. Physiol 1963; 18: 1123
    CrossrefPubMedGoogle Scholar
  • 13 Holemans R, Roberts H.R. Hageman factor and in vivo activation of fibrinolysis. J. Lab. clin. Med 1964; 64: 778
    PubMedGoogle Scholar
  • 14 Holemans R, Tysinger M.F. Site of origin of increased fibrinolytic activity during venous occlusion. Proc. Soc. exp. Biol. (N. Y.) 1965; 118: 448
    CrossrefPubMedGoogle Scholar
  • 15 Horowitz H.I, Wilcox W.P, Fujimoto M.M. Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma. Blood 1963; 22: 35
    PubMedGoogle Scholar
  • 16 Iatridis S.G, Ferguson J.H. Active Hageman factor: a plasma lysokinase of the human fibrinolytic system. J. clin. Invest 1962; 41: 1277
    CrossrefPubMedGoogle Scholar
  • 17 Iatridis S.G, Ferguson J.H. A two-stage assay method for Hageman factor activity. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 8: 46
    PubMedGoogle Scholar
  • 18 Iatridis S.G, Iatridis P.G, Ferguson J.H. The role of HF (factor XII) in the pathogenesis of the thrombolytic state induced by venous occlusion. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 16: 207
    PubMedGoogle Scholar
  • 19 Isacson S, Nilsson I.M, Pandolfi M. To be published.
    PubMed
  • 20 Isacson S, Pandolfi M, Nilsson IM. Decreased fibrinolytic activity in the veins of patients with thrombosis. (To be published 1968)
    PubMed
  • 21 Laurell C.-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt. Biochem 1966; 15: 45
    CrossrefPubMedGoogle Scholar
  • 22 Leandoer L, Bergentz S.-E, Nilsson I.M. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs. Thrombos. Diathes. haemorrh 1968; 19: 1 (Stuttg.)
    PubMedGoogle Scholar
  • 23 Niléhn J.-E. Separation and estimation of “Split Products” of fibrinogen and fibrin in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 18: 487
    PubMedGoogle Scholar
  • 24 Niléhn J.-E, Nilsson I.M. Demonstration of fibrinolytic split products in human serum by an immunological method in spontaneous and induced fibrinolytic states. Scand. J. Haemat 1964; 7: 313
    PubMedGoogle Scholar
  • 25 Niléhn J.-E, Robertson B. On the degradation products of fibrinogen of fibrin after infusion of streptokinase in patients with venous thrombosis. Scand. J. Haemat 1965; 2: 267
    PubMedGoogle Scholar
  • 26 Nilsson IM. Changes in the coagulation and fibrinolytic system predisposing to thrombosis Acta chir. scand. (In press) 1968
    PubMed
  • 27 Nilsson I.M, Blombäck M.I.v. Francken: On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand 1957; 159: 35
    PubMedGoogle Scholar
  • 28 Nilsson I.M, Blombäck M, Ramgren O. Haemophilia in Sweden. I. Coagulation studies. Acta med. scand 1961; 270: 665
    PubMedGoogle Scholar
  • 29 Nilsson I.M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand 1962; 125: 247
    PubMedGoogle Scholar
  • 30 Nilsson I.M, Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 8: 297
    PubMedGoogle Scholar
  • 31 Nilsson I.M, Skanse B, Gydell K. Fibrinolysis in Boeck's sarcoid. Acta med. scand 1957; 159: 463
    PubMedGoogle Scholar
  • 32 Pandolfi M, Nilsson I.M, Robertson B, Isacson S. Fibrinolytic activity of human veins. Lancet 1967; II: 127
    PubMedGoogle Scholar
  • 33 Pandolfi M, Robertson B, Isacson S, Nilsson I.M. Fibrinolytic activity of human veins in arms and legs. Thrombos. Diathes. haemorrh. (Stuttg.) 1968; 20: 247
    PubMedGoogle Scholar
  • 34 Paraskevas M, Nilsson I.M, Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest 1962; 14: 138
    CrossrefPubMedGoogle Scholar
  • 35 Robertson B. Personal communication 1968
    PubMed
  • 36 Soulier J.-P, Prou-Wartelle O. Nouvelles données sur les facteurs Hageman et PTA et sur le “contact”. Rev. franç. Étud. clin. biol 1959; 4: 932
    PubMedGoogle Scholar
  • 37 Steinbuch M, Blatrix C, Josso F. xis α2-macroglobulin as progressive antithrombin. Nature (Lond.) 1967; 216: 500
    CrossrefPubMedGoogle Scholar
  • 38 Tighe J.R, Swan H.T. Fibrinolysis and venous obstruction. Clin. Sci 1963; 25: 219
    PubMedGoogle Scholar